Scimitar - 2006 Equity Research

	Technology Review

	Sector Analysis

	2007 Reports

	2006 Reports

print this page

Please see our legal disclaimers within this disclosure section on the web site and/or on the last page of each company review or update. Past research reviews should not be relied upon for any purpose. Research reviews speak only as of the date of the review, and at any time thereafter may no longer be factually accurate and may not reflect our analyst's views on any security.

2006 Reports
		Advanced Research Technologies, Inc. (ARA.TO: TSX) 12.05.06 Filling the Coffers while Remapping the Future.

		StatSure Diagnostic Systems, Inc. (NASDAQ:SSUR; OTC: BB) 11.20.06 Rapid Point of Care Diagnostics for Near Term Cash Flow.

		Advanced Research Technologies, Inc. (ARA.TO: TSX) 11.16.06 Recapitalizing and Reorganizing with an Emphasis on Execution.

		Neurobiological Technologies, Inc. (NTII: NASDAQ) 11.14.06 A Rich Royalty Stream, Record Revenues, a Decreased Loss and a Completed Restatement.

		Advanced Research Technologies, Inc. (ARA.TO: TSX) 08.07.06 SoftScan® Advances Medical Device License Application in Canada.

		Advanced Research Technologies, Inc. (ARA.TO: TSX) 05.18.06 Strategic Investors Buying Again.

		Neurobiological Technologies, Inc. (NTII: NASDAQ) 05.11.06 First and Ten: Moving Ahead on Ancrod Stroke Clinical Trials.

		Advanced Research Technologies, Inc. (ARA.TO: TSX) 03.13.06 Acquisition Further Integrates to the Preclinical and Clinical Markets.

		Neurobiological Technologies, Inc. (NTII: NASDAQ) 02.13.06 Potential of Stroke Drug Would Fill a Huge Unmet Need.

		Neurobiological Technologies, Inc. (NTII: NASDAQ) 11.11.05 Advancing the Treatment Window.

		Advanced Research Technologies, Inc. (ARA.TO: TSX) 11.04.05 Directions to the Future.

		Neurobiological Technologies, Inc. (NTII: NASDAQ) 09.20.05 "Neurobiological Sells Brain Tumor Compound, XERECEPT® Rights for $33 Million"

		Neurobiological Technologies, Inc. (NTII: NASDAQ) 08.25.05 "Remember the Story of the Tortoise and the Hare."

		Advanced Research Technologies, Inc. (ARA.TO: TSX) 08.08.05 "Making R&D More Effective through Smarter Technologies."

		Neurobiological Technologies, Inc. (NTII: NASDAQ) 05.11.05 "Allocating to the Clinical Initiative."

		Advanced Research Technologies, Inc. (ARA.TO: TSX) 05.09.05 "Better Ways of Seeing What's Happening at the Molecular Level."

		ART Advanced Research Technologies, Inc. (ARA.TO, TSX) 03.23.05 "Achieving a Critical Mass".

		Neurobiological Technologies, Inc. (NTII: NASDAQ) 02.10.05 "A Convergence of Advancements."